drug class semaglutide Tirzepatide vs. Semaglutide: What You Should Know Weight-loss drug semaglutide shown to

Build a winning GLP-1 pharma marketing strategy that balances demand, safety concerns, and differentiation in a competitive market.

Among patients with obesity, semaglutide 7.2 mg reduced body weight by more than 18% for those without diabetes and by more than 13% for those with diabetes, according to the results of the STEP UP and STEP UP T2D trials

Ideal for those prioritizing convenience without compromising efficacy, they bridge the gap between lifestyle tweaks and advanced wellness

Glucagon-like peptide-1 (GLP-1) therapies are highly effective for weight loss and metabolic improvement in obesity and type 2 diabetes management

We help you embrace a healthy and active lifestyle one consultation at a time.

Here is the exact language that draws warning letters, and what to say instead.